As of 2026-04-11, the Relative Valuation of Calliditas Therapeutics AB (CALTX.ST) is (93.76) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 208.00 SEK, the upside of Calliditas Therapeutics AB based on Relative Valuation is -145.1%.
The range of the Relative Valuation is (85.43) - (130.79) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 16.3x | 11.2x |
| Forward P/E multiples | 10.7x - 16.5x | 12.2x |
| Fair Price | (85.43) - (130.79) | (93.76) |
| Upside | -141.1% - -162.9% | -145.1% |
| Date | P/E |